Abacus Life [ABL] vs Aflac [AFL] Detailed Stock Comparison

Abacus Life Inc.

NASDAQ
Loading...

Aflac Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Abacus Life Inc. wins in 7 metrics, Aflac Inc. wins in 13 metrics, with 0 ties. Aflac Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Abacus Life Inc. Aflac Inc. Better
P/E Ratio (TTM) 169.40 16.88 Aflac Inc.
Price-to-Book Ratio 1.90 2.02 Abacus Life Inc.
Debt-to-Equity Ratio 94.29 42.68 Aflac Inc.
PEG Ratio -0.85 -0.74 Aflac Inc.
EV/EBITDA 15.86 13.45 Aflac Inc.
Profit Margin (TTM) 5.62% 21.24% Aflac Inc.
Operating Margin (TTM) 35.59% 33.56% Abacus Life Inc.
EBITDA Margin (TTM) 35.59% 33.56% Abacus Life Inc.
Return on Equity 3.18% 13.12% Aflac Inc.
Return on Assets (TTM) 4.93% 2.54% Abacus Life Inc.
Free Cash Flow (TTM) $-209.62M $2.56B Aflac Inc.
Dividend Yield 3.02% 2.58% Abacus Life Inc.
1-Year Return 16.17% 15.29% Abacus Life Inc.
Price-to-Sales Ratio (TTM) 4.21 3.46 Aflac Inc.
Enterprise Value $1.14B $64.40B Aflac Inc.
EV/Revenue Ratio 5.82 3.75 Aflac Inc.
Gross Profit Margin (TTM) 87.84% N/A N/A
Revenue per Share (TTM) $2 $32 Aflac Inc.
Earnings per Share (Diluted) $0.05 $6.82 Aflac Inc.
Beta (Stock Volatility) -0.07 0.65 Abacus Life Inc.
Short % of Float 49.18% 2.08% Aflac Inc.

Abacus Life Inc. vs Aflac Inc. Stock Performance Analysis

Loading Price Chart...

ABL
AFL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Abacus Life Inc.-2.71%-10.94%-9.68%-13.90%20.99%4.80%
Aflac Inc.1.38%2.30%5.92%8.91%14.15%13.13%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Abacus Life Inc.16.17%-12.73%-8.37%-7.99%-7.99%-7.99%
Aflac Inc.15.29%69.67%126.19%242.44%423.32%407.10%

Performance & Financial Health Analysis: Abacus Life Inc. vs Aflac Inc.

MetricABLAFL
Market Information
Market Cap i$971.66M$59.05B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i495,8492,109,423
90 Day Avg. Volume i483,8222,335,318
Last Close$8.98$124.72
52 Week Range$4.60 - $10.53$96.95 - $125.93
% from 52W High-14.76%-0.96%
All-Time High$13.25 (Feb 05, 2024)$125.93 (Jul 17, 2026)
% from All-Time High-32.23%-0.96%
Growth Metrics
Quarterly Revenue Growth1.24%-0.10%
Quarterly Earnings Growth1.24%-0.28%
Financial Health
Profit Margin (TTM) i0.06%0.21%
Operating Margin (TTM) i0.36%0.34%
Return on Equity (TTM) i0.03%0.13%
Debt to Equity (MRQ) i94.2942.68
Cash & Liquidity
Book Value per Share (MRQ)$4.45$56.86
Cash per Share (MRQ)$0.88$14.78
Operating Cash Flow (TTM) i$-110,223,816$2.56B
Levered Free Cash Flow (TTM) i$41.56M$5.18B
Dividends
Last 12-Month Dividend Yield i3.02%2.58%
Last 12-Month Dividend i$0.20$2.93

Valuation & Enterprise Metrics Analysis: Abacus Life Inc. vs Aflac Inc.

MetricABL (Mar 05, 2026)AFL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i169.4016.88
Forward P/E i8.5614.93
PEG Ratio i-0.85-0.74
Price to Sales (TTM) i4.213.46
Price to Book (MRQ) i1.902.02
Market Capitalization
Market Capitalization i$971.66M$59.05B
Enterprise Value i$1.14B$64.40B
Enterprise Value Metrics
Enterprise to Revenue i5.823.75
Enterprise to EBITDA i15.8613.45
Risk & Other Metrics
Beta i-0.070.65
Book Value per Share (MRQ) i$4.45$56.86

Financial Statements Comparison: Abacus Life Inc. vs Aflac Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricABL (2024)AFL (2025)
Revenue/Sales i111.92M17.36B
Cost of Goods Sold i11.37MN/A
COGS % of Revenue i10.2%0.0%
Gross Profit i100.55MN/A
Gross Margin i89.8%0.0%
Research & Development iN/AN/A
Operating Income (EBIT) i1.84MN/A
Operating Margin i1.6%0.0%
EBITDA i12.19MN/A
EBITDA Margin i10.9%0.0%
Pre-Tax Income i-19.43M4.53B
Pre-Tax Income % of Revenue i-17.4%26.1%
Income Tax i5.48M887.00M
Income Tax % of Revenue i4.9%5.1%
Net Income (Profit) i-24.92M3.65B
Profit Margin i-22.3%21.0%

Balance Sheet & Liquidity Metrics

MetricABL (2024)AFL (2025)
Cash & Equivalents i131.94M6.25B
Total Current Assets i159.56MN/A
Total Current Assets % of Revenue i142.6%0.0%
Total Current Liabilities i62.47MN/A
Total Current Liabilities % of Revenue i55.8%0.0%
Long-Term Debt i346.97M8.41B
Long-Term Debt % of Revenue i310.0%48.5%
Total Shareholders Equity i423.29M29.49B
Retained Earnings i-57.90M54.68B
Retained Earnings % of Revenue i-51.7%315.1%
Property, Plant & Equipment i4.72MN/A

Cash Flow Statement Comparison

MetricABL (2024)AFL (2025)
Operating Cash Flow i-213.60M3.50B
Operating Cash Flow % of Revenue i-190.8%20.2%
Capital Expenditures i-786,236N/A
Free Cash Flow i-209.62M2.56B
FCF Margin i-187.3%14.7%
Debt Repayment i-32.23M-84.00M
Common Stock Repurchase i-10.74M-3.53B

Short Interest & Institutional Ownership Analysis

MetricABLAFL
Shares Short i6.48M8.35M
Short Ratio i8.953.23
Short % of Float i49.18%2.08%
Shares Outstanding i97.70M518.69M
Float Shares i32.63M512.03M
% Held by Insiders i61.69%10.85%
% Held by Institutions i30.86%59.81%
% Held by Public i7.45%29.34%

Dividend Analysis & Yield Comparison: Abacus Life Inc. vs Aflac Inc.

MetricABLAFL
Last 12-Month Dividend i$0.20$2.93
Last 12-Month Dividend Yield i3.02%2.58%
3-Year Avg Annual Dividend i$0.07$2.06
3-Year Avg Dividend Yield i3.02%0.55%
3-Year Total Dividends i$0.20$6.19
Ex-Dividend DateDec 02, 2025Feb 18, 2026